Cargando…

Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study

BACKGROUND: While the factors for poor adherence for treatment with statins have been highlighted, the impact of their combination on adherence is not clear. AIMS: To estimate adherence for statins and whether it differs according to the number of cardiovascular risk factors. METHODS: A cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latry, Philippe, Molimard, Mathieu, Dedieu, Bernard, Couffinhal, Thierry, Bégaud, Bernard, Martin-Latry, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160410/ https://www.ncbi.nlm.nih.gov/pubmed/21791073 http://dx.doi.org/10.1186/1471-2261-11-46

Ejemplares similares

Relationship between Obesity and Massive Transfusion Needs in Trauma Patients, and Validation of TASH Score in Obese Population: A Retrospective Study on 910 Trauma Patients
por: De Jong, Audrey, et al.
Publicado: (2016)

Performance Characteristics of Breezhaler(®) and Aerolizer(®) in the Real-World Setting
por: Molimard, Mathieu, et al.
Publicado: (2021)

Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk
por: Fung, Vicki, et al.
Publicado: (2018)

Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE
por: Banach, Maciej, et al.
Publicado: (2021)

Improving the physician-patient cardiovascular risk dialogue to improve statin adherence
por: Casebeer, Linda, et al.
Publicado: (2009)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
por: Goldenberg, Naila, et al.
Publicado: (2009)

Statin utilisation in a real‐world setting: a retrospective analysis in relation to arterial and cardiovascular autonomic function
por: Sluyter, John D., et al.
Publicado: (2016)

When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
por: Catalá-López, Ferrán, et al.
Publicado: (2013)

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting
por: Ezhov, Marat V., et al.
Publicado: (2023)

Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you need
por: Bitzur, Rafael
Publicado: (2011)

When Should Statins Be Stopped?
por: Bibi, Mário, et al.
Publicado: (2021)

Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”
por: Diamond, David M., et al.
Publicado: (2019)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Adherence to Statins in Primary Prevention: Yearly Adherence Changes and Outcomes
por: Slejko, Julia F., et al.
Publicado: (2014)

Systemic Corticosteroids for Treating Respiratory Diseases: Less Is Better, but… When and How Is It Possible in Real Life?
por: Melani, Andrea S., et al.
Publicado: (2023)

Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy
por: Degli Esposti, Luca, et al.
Publicado: (2022)

Impact of physician’ and pharmacy staff supporting activities in usual care on patients’ statin adherence
por: Huiskes, Victor Johan Bernard, et al.
Publicado: (2022)

Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
por: Maumus-Robert, Sandy, et al.
Publicado: (2023)

Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?
por: Chapman, Richard H, et al.
Publicado: (2009)

Association of Continuity of Primary Care and Statin Adherence
por: Warren, James R., et al.
Publicado: (2015)

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
por: Murphy, Michael J, et al.
Publicado: (2008)

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice
por: Fairman, Kathleen A, et al.
Publicado: (2017)

When bigger is better
por: Petsko, Gregory A
Publicado: (2010)

When more is better
por: Pichard, Claude
Publicado: (2014)

The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points
por: Bijlsma, Maarten J., et al.
Publicado: (2016)

Are pleiotropic effects of statins real?
por: Corsini, Alberto, et al.
Publicado: (2007)

Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk
por: Lin, Iris, et al.
Publicado: (2016)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence
por: Lavikainen, Piia, et al.
Publicado: (2016)

A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments
por: Schneider, Marie Paule, et al.
Publicado: (2019)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
por: Chen, Shu-ting, et al.
Publicado: (2019)

Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study
por: Rezende Macedo do Nascimento, Renata Cristina, et al.
Publicado: (2020)

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study
por: Casula, M., et al.
Publicado: (2020)

Impact of prescription size on statin adherence and cholesterol levels
por: Batal, Holly A, et al.
Publicado: (2007)

Statin non-adherence: clinical consequences and proposed solutions
por: Rosenson, Robert S.
Publicado: (2016)

Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review
por: Arlegui, Hugo, et al.
Publicado: (2020)

Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients
por: Humbert, Marc, et al.
Publicado: (2022)

Statin Hepatotoxicity: Is it a Real Concern?
por: Sikka, Pranav, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rk5a4uad620iga5tfe4tqfj551